Cortisol awakening response in bipolar patients with comorbid type 2 diabetes mellitus

References

• Andrews RC, Herlihy O, Livingstone DEW, Andrew R, Walker BR. 2002. Abnormal cortisol metabolism and tissue sensitivity to cortisol in patients with glucose intolerance. J Clin Endocrinol Metab. 87(12):5587–5593.
   PubMed Web of Science ®Google Scholar
• Belvederi Murri M, Prestia D, Mondelli V, Pariante C, Patti S, Olivieri B, Arzani C, Masotti M, Respino M, Antonioli M, et al. 2016. The HPA axis in bipolar disorder: systematic review and meta-analysis. Psychoneuroendocrinology. 63:327–342.
   PubMed Web of Science ®Google Scholar
• Bruehl H, Wolf OT, Convit A. 2009. A blunted cortisol awakening response and hippocampal atrophy in type 2 diabetes mellitus. Psychoneuroendocrinology. 34(6):815–821.
   PubMed Web of Science ®Google Scholar
• Buchanan TW, Kern S, Allen JS, Tranel D, Kirschbaum C. 2004. Circadian regulation of cortisol after hippocampal damage in humans. Biol Psychiatry. 56(9):651–656.
   PubMed Web of Science ®Google Scholar
• Calkin CV, Ruzickova M, Uher R, Hajek T, Slaney CM, Garnham JS, O'Donovan MC, Alda M. 2015. Insulin resistance and outcome in bipolar disorder. Br J Psychiatry. 206(1):52–57.
   PubMed Web of Science ®Google Scholar
• Champaneri S, Xu X, Carnethon MR, Bertoni AG, Seeman T, D, Roux A, Golden SH. 2012. Diurnal salivary cortisol and urinary catecholamines are associated with diabetes mellitus: the Multi-Ethnic Study of Atherosclerosis. Metabolism. 61(7):986–995.
   PubMed Web of Science ®Google Scholar
• Charles EF, Lambert CG, Kerner B. 2016. Bipolar disorder and diabetes mellitus: evidence for disease-modifying effects and treatment implications. Int J Bipolar Disord. 4(1):13.
   PubMedGoogle Scholar
• Chiodini I, Torlontano M, Scillitani A, Arosio M, Bacci S, Di Lembo S, Epaminonda S, Augello G, Enrini R, Ambrosi B, et al. 2005. Association of subclinical hypercortisolism with type 2 diabetes mellitus: a case-control study in hospitalized patients. Eur j Endocrinol. 153(6):837–844.
   PubMed Web of Science ®Google Scholar
• Cohen J. 1992. A power primer. Psychol Bull. 112(1):155–159.
   PubMed Web of Science ®Google Scholar
• Correll CU, Solmi M, Veronese N, Bortolato B, Rosson S, Santonastaso P, Thapa-Chhetri N, Fornaro M, Gallicchio D, Collantoni E, et al. 2017. Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls. World Psychiatry. 16(2):163–180.
   PubMed Web of Science ®Google Scholar
• Delle Chiaie R, Trabucchi G, Girardi N, Marini I, Pannese R, Vergnani L, Caredda M, Zerella MP, Minichino A, Corrado A, et al. 2013. Group psychoeducation normalizes cortisol awakening response in stabilized bipolar patients under pharmacological maintenance treatment. Psychother Psychosom. 82(4):264–266.
   PubMed Web of Science ®Google Scholar
• den Heijer T, Vermeer SE, van Dijk EJ, Prins ND, Koudstaal PJ, Hofman A, Breteler MMB. 2003. Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI. Diabetologia. 46(12):1604–1610.
   PubMed Web of Science ®Google Scholar
• Deshauer D, Duffy A, Alda M, Grof E, Albuquerque J, Grof P. 2003. The cortisol awakening response in bipolar illness: a pilot study. Can J Psychiatry. 48(7):462–466.
   PubMed Web of Science ®Google Scholar
• Deshauer D, Duffy A, Meaney M, Sharma S, Grof P. 2006. Salivary cortisol secretion in remitted bipolar patients and offspring of bipolar parents. Bipolar Disord. 8(4):345–349.
   PubMed Web of Science ®Google Scholar
• Fekedulegn DB, Andrew ME, Burchfiel CM, Violanti GM, Hartley TA, Charles LE, Miller DB. 2007. Area under the curve and other summary indicators of repeated waking cortisol measurements. Psychosom Med. 69(7):651–659.
   PubMed Web of Science ®Google Scholar
• First MB, Gibbon M, Spitzer RL, Williams JBW. 1996. Structured clinical interview for axis I DSM-IV disorders, non-patient ed – (SCID-I/NP, version 2.0). New York (NY): New York State Psychiatric Institute, Biometrics Research Department.
   Google Scholar
• Godoy-Matos AF, Vieira AR, Moreira RO, Coutinho WF, Carraro LM, Moreira DM, Pasquali R, Meirelles RMR. 2006. The potential role of increased adrenal volume in the pathophysiology of obesity-related type 2 diabetes. J Endocrinol Invest. 29(2):159–163.
   PubMed Web of Science ®Google Scholar
• Gold SM, Dziobek I, Sweat V, Tirsi A, Rogers K, Bruehl H, Tsui W, Richardson S, Javier E, Convit A. 2007. Hippocampal damage and memory impairments as possible early brain complications of type 2 diabetes. Diabetologia. 50(4):711–719.
   PubMed Web of Science ®Google Scholar
• Guo L, Stormmesand J, Fang Z, Zhu Q, Balesar R, van Heerikhuize J, Sluiter A, Swaab D, Bao AM. 2019. Quantification of tyrosine hydroxylase and ErbB4 in the locus coeruleus of mood disorder patients using a multispectral method to prevent interference with immunocytochemical signals by neuromelanin. Neurosci Bull. 35(2):205–215.
   PubMed Web of Science ®Google Scholar
• Hackett RA, Steptoe A, Kumari M. 2014. Association of diurnal patterns in salivary cortisol with type 2 diabetes in the Whitehall II study. J Clin Endocrinol Metab. 99(12):4625–4631.
   PubMed Web of Science ®Google Scholar
• Hajek T, Calkin C, Blagdon R, Slaney C, Alda M. 2015. Type 2 diabetes mellitus: a potentially modifiable risk factor for neurochemical brain changes in bipolar disorders. Biol Psychiatry. 77(3):295–303.
   PubMed Web of Science ®Google Scholar
• Hajek T, Calkin C, Blagdon R, Slaney C, Uher R, Alda M. 2014. Insulin resistance, diabetes mellitus, and brain structure in bipolar disorders. Neuropsychopharmacology. 39(12):2910–2918.
   PubMed Web of Science ®Google Scholar
• Hobson JA, Pace-Schott EF. 2002. The cognitive neuroscience of sleep: neuronal systems, consciousness and learning. Nat Rev Neurosci. 3(9):679–693.
   PubMed Web of Science ®Google Scholar
• Huang MC, Chuang SC, Tseng MCM, Chien YL, Liao SC, Chen HC, Kuo PH. 2017. Cortisol awakening response in patients with bipolar disorder during acute episodes and partial remission: a pilot study. Psychiatry Res. 258:594–597.
   PubMed Web of Science ®Google Scholar
• Joseph JJ, Wang X, Spanakis E, Seeman T, Wand G, Needham B, Golden SH. 2015. Diurnal salivary cortisol, glycemia and insulin resistance: the multi-ethnic study of atherosclerosis. Psychoneuroendocrinology. 62:327–335.
   PubMed Web of Science ®Google Scholar
• Khan A, Faucett J, Morrison S, Brown WA. 2013. Comparative mortality risk in adult patients with schizophrenia, depression, bipolar disorder, anxiety disorders, and attention-deficit/hyperactivity disorder participating in psychopharmacology clinical trials. JAMA Psychiatry. 70(10):1091.
   PubMed Web of Science ®Google Scholar
• Kudielka BM, Hellhammer DH, Wüst S. 2009. Why do we respond so differently? Reviewing determinants of human salivary cortisol responses to challenge. Psychoneuroendocrinology. 34(1):2–18.
   PubMed Web of Science ®Google Scholar
• Laursen TM, Wahlbeck K, Hällgren J, Westman J, Ösby U, Alinaghizadeh H, Gissler M, Nordentoft M. 2013. Life expectancy and death by diseases of the circulatory system in patients with bipolar disorder or schizophrenia in the Nordic countries. PLoS One. 8(6):e67133.
   PubMed Web of Science ®Google Scholar
• Lederbogen F, Hummel J, Fademrecht C, Krumm B, Kühner C, Deuschle M, Ladwig KH, Meisinger C, Wichmann HE, Lutz H, et al. 2011. Flattened circadian cortisol rhythm in type 2 diabetes. Exp Clin Endocrinol Diabetes. 119(9):573–575.
   PubMed Web of Science ®Google Scholar
• Lee ZSK, Chan JCN, Yeung VTF, Chow CC, Lau MS, Ko GT, Li JK, Cockram CS, Critchley JA. 1999. Plasma insulin, growth hormone, cortisol, and central obesity among young Chinese type 2 diabetic patients. Diabetes Care. 22(9):1450–1457.
   PubMed Web of Science ®Google Scholar
• Liu H, Bravata DM, Cabaccan J, Raff H, Ryzen E. 2005. Elevated late-night salivary cortisol levels in elderly male type 2 diabetic veterans. Clin Endocrinol. 63(6):642–649.
   PubMed Web of Science ®Google Scholar
• Montgomery SA, Asberg M. 1979. A new depression scale designed to be sensitive to change. Br J Psychiatry. 134:382–389.
   PubMed Web of Science ®Google Scholar
• Proudfoot J, Doran J, Manicavasagar V, Parker G. 2011. The precipitants of manic/hypomanic episodes in the context of bipolar disorder: a review. J Affect Disord. 133(3):381–387.
   PubMed Web of Science ®Google Scholar
• Pruessner M, Lepage M, Collins DL, Pruessner JC, Joober R, Malla AK. 2015. Reduced hippocampal volume and hypothalamus-pituitary-adrenal axis function in first episode psychosis: evidence for sex differences. Neuroimage Clin. 7:195–202.
   PubMed Web of Science ®Google Scholar
• Pruessner M, Pruessner JC, Hellhammer DH, Bruce Pike G, Lupien SJ. 2007. The associations among hippocampal volume, cortisol reactivity, and memory performance in healthy young men. Psychiatry Res. 155(1):1–10.
   PubMed Web of Science ®Google Scholar
• Regenold WT, Thapar RK, Marano C, Gavirneni S, Kondapavuluru PV. 2002. Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use. J Affect Disord. 70(1):19–26.
   PubMed Web of Science ®Google Scholar
• Stalder T, Kirschbaum C, Kudielka BM, Adam EK, Pruessner JC, Wüst S, Dockray S, Smyth N, Evans P, Hellhammer DH, et al. 2016. Assessment of the cortisol awakening response: expert consensus guidelines. Psychoneuroendocrinology. 63:414–432.
   PubMed Web of Science ®Google Scholar
• Steardo L, Fabrazzo M, Sampogna G, Monteleone AM, D'Agostino G, Monteleone P, Maj M. 2019. Impaired glucose metabolism in bipolar patients and response to mood stabilizer treatments. J Affect Disord. 245:174–179.
   PubMed Web of Science ®Google Scholar
• Straub RH, Buttgereit F, Cutolo M. 2011. Alterations of the hypothalamic-pituitary-adrenal axis in systemic immune diseases - a role for misguided energy regulation. Clin Exp Rheumatol. 29(5 Suppl 68):S23–S31.
   PubMed Web of Science ®Google Scholar
• Subramaniam A, LoPilato A, Walker EF. 2019. Psychotropic medication effects on cortisol: implications for research and mechanisms of drug action. Schizophr Res. 213:6–14.
   PubMed Web of Science ®Google Scholar
• Ulrich-Lai YM, Herman JP. 2009. Neural regulation of endocrine and autonomic stress responses. Nat Rev Neurosci. 10(6):397–409.
   PubMed Web of Science ®Google Scholar
• Wiste AK, Arango V, Ellis SP, Mann JJ, Underwood MD. 2008. Norepinephrine and serotonin imbalance in the locus coeruleus in bipolar disorder. Bipolar Disord. 10(3):349–359.
   PubMed Web of Science ®Google Scholar
• Young RC, Biggs JT, Ziegler VE, Meyer DA. 1978. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. 133:429–435.
   PubMed Web of Science ®Google Scholar